The patient must have recovered from surgery with the incision completely healed and no signs of infection
Must have adequate recovery from prior surgery (e.g., healed scar, resumption of diet, etc.)
Recovery from surgery with the incision completely healed and no signs of infection
At least 4 weeks from completion of major surgery and a healed surgical incision
Major surgery must be completed greater than 28 days prior to registration for protocol therapy and healed surgical incision is required
Major surgery within prior 4 weeks of treatment initiation (the surgical incision should be fully healed prior to all neoadjuvant treatment initiation)
Major surgery within 4 weeks of enrollment, or a wound that has not fully healed
Major surgery or a wound that has not fully healed within 4 weeks of enrollment
Major surgery =< 4 weeks prior to registration (the surgical incision should be fully healed prior to drug administration or radiation therapy)
Major surgery or a wound that has not fully healed within 4 weeks of enrollment
Major surgery or a wound that has not fully healed within 4 weeks of enrollment
Major surgery within 4 weeks of study entry, or wound that is not healed from prior surgery or\r\ntrauma
Patients must be a minimum of 3 weeks from thoracotomy (if performed) and well-healed before starting treatment
Major surgery or a wound that has not fully healed within 4 weeks of initiation of therapy
Non-healed infected skin ulcers
Resected patients should begin treatment within 24 weeks of surgery, once adequately healed as determined by the treating physicians
Patients with non-healed wounds.
Major surgery or wound that has not fully healed within 4 weeks or vaccination with live attenuated vaccines within 4 weeks of the first dose of study drugs.
Major surgery within prior 4 weeks (the surgical incision should be fully healed prior to drug administration)
Patients with wounds that have not fully healed are not eligible
Patient has had major surgery or a wound that has not fully healed within 4 weeks of starting study drugs
Incompletely healed surgical incision prior to enrollment
No defined washout period from major or minor surgery is required but incisions must be fully healed
Participants must be at least 4 weeks from prior surgical procedures and surgical incisions must be healed
Surgical or other wounds must be adequately healed prior to enrollment.
Major surgery within 4 weeks of enrollment; any and all surgical incisions must be fully healed prior to study enrollment; Note: recent port placement for chemotherapy administration is not considered an exclusionary surgical incision
Craniotomy wound that has not sufficiently healed
Incompletely healed wound
Major surgery or a wound that has not fully healed within 4 weeks of enrollment
Non-healed wound;
Major surgery within 4 weeks prior to entry into the study, or a surgical incision that is not fully healed
Major surgery with incompletely healed surgical incision before starting study therapy
Major surgery or a wound that has not fully healed =< 4 weeks prior to registration
Major surgery or a wound that has not fully healed within 4 weeks of treatment
Any non-cranial surgery within 4 weeks of study registration; must be recovered and fully healed from any prior surgery
Postsurgical open wound that has not healed at the time of enrollment.
Major surgery or a wound that has not fully healed within 4 weeks of starting ibrutinib
Major injuries or surgery (e.g., craniotomy) < 28 days from the start of nintedanib/placebo administration; wound should be healed prior to starting therapy
Post-surgical open wound that has not been healed at the time of enrollment
Residual grade > 1 skin toxicity, cellulitis, or incompletely healed wound(s) at intended site of study drug application at the time of the start of radiation therapy (RT)
Major surgery within 4 weeks or incompletely healed surgical incision before starting study therapy